New method to evaluate the distribution of metastatic tumor cells in bone marrow with bromodeoxyuridine labeling

Background The development of tumor micrometastases as an early event in the distribution of tumor cells to target organs, especially bone marrow, has been difficult to analyze due to a lack of suitably sensitive markers. The inability to discriminate small numbers of tumor cells from normal tissue cell populations has interfered with marker development.